News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infection Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 1 Sep 2026 Analysis of the therapeutic gap for Trypanosoma cruzi infection in Colombia (2012 – 2022) Memórias do Instituto Oswaldo Cruz
Viewpoints 26 Feb 2015 Will Crisis See a Long-Awaited Response to Lack of Innovation and Access Come from Public Leadership?
Viewpoints 27 Jun 2014 Conducting clinical trials for sleeping sickness in remote areas of the Democratic Republic of the Congo – Overcoming Operational Challenges and Reaping Health System Benefits
Viewpoints 22 May 2014 Modern drug discovery and the fight against NTDs: How can the PDP model enhance and accelerate the R&D process?
Viewpoints 3 Apr 2014 Global Alliance for the Treatment of Chagas Disease: Thinking About the Patients
Viewpoints 12 Nov 2013 WHO R&D ‘Demonstration Projects’: A Member State-driven step towards a sustainable global framework for neglected disease R&D
Viewpoints 11 Sep 2013 The Role of Neglected Disease-Endemic, Emerging-Economy Countries in Neglected Disease R&D: Latin America on the Rise
Viewpoints 13 May 2013 Connect to Fight Neglect: A Decade of Medical Innovations for Neglected Patients
Viewpoints 3 Oct 2012 Regulatory Harmonization in Developing Countries Needed to Speed up Neglected Patients’ Access to New Drugs
